Navigating the mental health impact of GLP-1s...

Burnout gets all the attention, but some employees struggle with a different problem: chronic boredom on the job, sometimes called "boreout." Lotta Harju, PhD, of EM Lyon Business School, and Sharon K. Parker, PhD, of Curtin University, discuss how boreout differs from burnout, h ...  Show more

The U.S. suicide rate today is almost identical to what it was a century ago, even as death rates from many other causes have dropped. Matthew Nock, PhD, of Harvard University, discusses why it’s so hard to predict who will act on suicidal thoughts -- and when; how new tools, fro ...  Show more

Let's dive into the rise of GLP-1 medications and what they mean for both the body and the mind. From Serena Williams stepping in as the face of Ro’s GLP-1 campaign, to Kyla’s personal weight loss journey, we explore the intersections of medicine, celebrity culture, and lived exp ...  Show more

GLP-1 drugs like Ozempic™ and Wegovy™ do a great job at helping folks lose large amounts of weight, but there is emerging evidence that the benefits go well beyond achieving a healthy weight. And then there is the dark side…can they also harm? In this episode, Dr. Alexandra Sowa, ...  Show more

In this episode of The Oprah Podcast, Oprah continues her conversation with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, about the anti-obesity GLP-1 medications that are changing the world of weight loss. Oprah and Dr. Ania talk ...  Show more

Ozempic, Wegovy, and Mounjaro, are being called “miracle drugs” with users boasting about their fast results. Dr. Sanjay Gupta takes a deep dive into how they disrupted the entire weight loss industry and changed the conversation about obesity.  Learn more about your ad choices. ...  Show more